Plasma Exchange Treatment in Five Kawasaki Disease Patients Unresponsive to Intravenous Immunoglobulin
Open Access
- 30 June 2023
- journal article
- research article
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 1 (1)
Abstract
The efficacy of high-dose intravenous immunoglobulin (IVIG) treatment for acute-stage Kawasaki disease patients has become widely recognized. However, in the case of refractory Kawasaki disease, alternative treatment should be considered to prevent coronary artery abnormality (CAA). Here, we present several cases of Kawasaki disease in children treated with plasma exchange (PE). We retrospectively reviewed the medical records of 5 subjects who had been unresponsive to IVIG treatments and treated with PE consecutively. The fever subsided and the other clinical manifestations were improved after PE in all cases. In two cases, giant coronary artery aneurysms were detected on echocardiographic follow-up study. PE should be a method with promising efficacy and might be considered in refractory Kawasaki disease patients for whom other treatment options have failed.Keywords
This publication has 21 references indexed in Scilit:
- Therapeutic plasma exchange in systemic vasculitisCurrent Opinion in Rheumatology, 2012
- Long‐term efficacy of plasma exchange treatment for refractory Kawasaki diseasePediatrics International, 2011
- New Equations and a Critical Appraisal of Coronary Artery Z Scores in Healthy ChildrenJournal of the American Society of Echocardiography, 2011
- Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki DiseaseCirculation, 2006
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Plasma exchange for refractory Kawasaki diseaseEuropean Journal of Pediatrics, 2004
- Selective high dose gamma-globulin treatment in Kawasaki disease: Assessment of clinical aspects and cost effectivenessPediatrics International, 1999
- Long-term Consequences of Kawasaki DiseaseCirculation, 1996
- Plasma exchange in Kawasaki diseaseThe Lancet, 1995
- Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki diseaseThe Journal of Pediatrics, 1994